COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,612 Articles (22,913 medRxiv, 8,699 bioRxiv)

Most recent first Previous |  Page 2368: Articles 23671-23680  | Next

A delayed SEIQR epidemic model of COVID-19 in Tokyo
Maki, K.
10.1101/2020.08.18.20177709 — Posted: 2020-08-22
Disparities in COVID-19 Hospitalizations and Mortality among Black and Hispanic Patients: Cross-Sectional Analysis from the Greater Houston Metropolitan Area
Pan, A., Khan, O., Meeks, J., Boom, M., Masud, F., Andrieni, J., Phillips, R., Tiruneh, Y., Kash, B., Vahidy, F.
10.1101/2020.08.19.20177956 — Posted: 2020-08-22
Epidemic Analysis of COVID-19 in Egypt, Qatar and Saudi Arabia using the Generalized SEIR Model
Fahmy, A. E., Eldesouky, M. M., Mohamed, A. S. A.
10.1101/2020.08.19.20178129 — Posted: 2020-08-22
Lockdown, relaxation, and ACME period in COVID-19: A study of disease dynamics on Hermosillo, Sonora, Mexico
Tocto-Erazo, M., Espindola-Zepeda, J. A., Montoya-Laos, J. A., Acuna-Zegarra, M. A., Olmos-Liceaga, D., Reyes-Castro, P. A., Figueroa-Preciado, G.
10.1101/2020.08.20.20178509 — Posted: 2020-08-22
Evaluating aerosol and splatter during orthodontic debonding: implications for the COVID-19 pandemic
Llandro, H., Allison, J., Currie, C., Edwards, D., Bowes, C., Durham, J., Jakubovics, N., Rostami, N., Holliday, R.
10.1101/2020.08.19.20178319 — Posted: 2020-08-22 Discussion: Offsite
Functional and druggability analysis of the SARS-CoV-2 proteome
Cavasotto, C. N., Sanchez Lamas, M., Maggini, J.
10.1101/2020.08.21.261404 — Posted: 2020-08-22
Recombinant SARS-CoV-2 RBD molecule with a T helper epitope as a built in adjuvant induces strong neutralization antibody response
Su, Q., Zou, Y., Yi, Y., Shen, L., Ye, C., Zhang, Y., Wang, H., Ke, H., Song, J., Hu, K., Cheng, B., Qiu, F., Yu, P., Zhou, W., Cao, L., Bi, S., Wu, G., Gao, G. F., Zheng, J.
10.1101/2020.08.21.262188 — Posted: 2020-08-22
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.
Jaimez, J. J., Macias, R., Bermudez, F., Rubini, R., Alvarez, M., Tercedor, L., Mediavilla, J. D., Ramirez, J., Morales, C., Flores, P.
10.1101/2020.08.18.20177717 — Posted: 2020-08-22
Whether Early Pulse Steroid dose is associated with lower mortality in COVID-19 critically ill Patients- A retrospective Chart Review
Goyal, A., saigal, s., Joshi, A., Niwariya, Y., Brahmam, D., Khurana, A., Singh, P., Sharma, J., Karna, S. T., Khadanga, S., Mitra, A.
10.1101/2020.08.19.20171868 — Posted: 2020-08-22
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey
ALKURT, G., MURT, A., AYDIN, Z., TATLI, O., AGAOGLU, N. B., IRVEM, A., AYDIN, M., KARAALI, R., GUNES, M., YESILYURT, B., TURKEZ, H., MARDINOGLU, A., DOGANAY, M., BASINOGLU, F., SEYAHI, N., DINLER DOGANAY, G., DOGANAY, L.
10.1101/2020.08.19.20178095 — Posted: 2020-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).